Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Evolus Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
EOLS
Nasdaq
8731
https://www.evolus.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Evolus Inc
Evolus to Participate in the 23rd Annual Needham Virtual Healthcare Conference
- Mar 26th, 2024 12:00 pm
10 Stocks George Soros and Insiders Are Crazy About
- Mar 14th, 2024 11:04 am
Does Evolus, Inc. (EOLS) Have the Potential to Rally 63.24% as Wall Street Analysts Expect?
- Mar 13th, 2024 1:55 pm
Evolus Announces Pricing of $50.0 Million Underwritten Offering of Common Stock
- Mar 11th, 2024 11:00 am
Analyst Estimates: Here's What Brokers Think Of Evolus, Inc. (NASDAQ:EOLS) After Its Full-Year Report
- Mar 10th, 2024 1:16 pm
Evolus Full Year 2023 Earnings: In Line With Expectations
- Mar 9th, 2024 1:09 pm
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Mar 8th, 2024 9:05 pm
Evolus, Inc. (NASDAQ:EOLS) Q4 2023 Earnings Call Transcript
- Mar 8th, 2024 8:24 pm
Q4 2023 Evolus Inc Earnings Call
- Mar 8th, 2024 5:30 pm
Evolus Inc (EOLS) Reports Record Revenues in Q4 and Full Year 2023, Eyes Profitability in 2024
- Mar 8th, 2024 3:34 am
Evolus Reports Record Fourth Quarter and Full Year 2023 Financial Results; Reaffirms 2024 Guidance
- Mar 7th, 2024 9:05 pm
11 Best Small Cap Pharma Stocks to Invest In
- Mar 5th, 2024 1:28 am
Evolus Announces Results from European Head-to-Head Filler Trial
- Mar 1st, 2024 1:30 pm
Evolus to Participate in Upcoming Leerink Partners and Barclays Investor Conferences
- Feb 27th, 2024 1:30 pm
Evolus to Report Fourth Quarter and Year End 2023 Results and Provide Business Update on March 7, 2024
- Feb 22nd, 2024 9:30 pm
Evolus Inc Director Karah Parschauer Sells 11,931 Shares
- Feb 3rd, 2024 2:10 am
Evolus Insider Ups Holding By 210% During Year
- Jan 25th, 2024 11:28 am
Evolus Announces Preliminary Unaudited Fourth Quarter and Full-Year 2023 Net Revenue, Achieving Record Results and Exceeding Expectations; Issues 2024 Guidance
- Jan 16th, 2024 10:28 pm
Wall Street Analysts See a 133.85% Upside in Evolus, Inc. (EOLS): Can the Stock Really Move This High?
- Jan 9th, 2024 11:21 pm
Evolus Announces the Appointment of Nareg Sagherian to Vice President, Head of Global Investor Relations and Corporate Communications
- Jan 4th, 2024 9:05 pm
Scroll